U.S. Markets closed

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
18.20+0.69 (+3.94%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue81,32150,28626,551
Cost of Revenue2,0581,361882
Gross Profit79,26348,92525,669
Operating Expenses
Research Development23,84415,41918,372
Selling General and Administrative45,24036,94934,916
Non Recurring---
Total Operating Expenses---
Operating Income or Loss10,179-3,443-27,619
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes10,179-3,443-27,619
Interest Expense2,0392,9653,764
Income Before Tax8,140-6,408-31,383
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops8,140-6,408-31,383
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income8,140-6,408-31,383
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares8,140-6,408-31,383